Bowel Cancer Trial Sees Zero Relapses After 33 Months

A groundbreaking clinical trial using immunotherapy before surgery instead of chemotherapy after has kept every single bowel cancer patient relapse-free for nearly three years.

The results could transform treatment for one of the deadliest cancers affecting young adults.